Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-19-024500)

Filing Details

Accession Number:: 0001209191-19-024500
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-04-12 17:16:08
Reporting Period:: 2019-04-01

Accepted Time:: 2019-04-12 17:16:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1087294	Cumberland Pharmaceuticals Inc	CPIX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1075050	J A Kazimi	2525 West End Ave. Suite 950 Nashville TN 37203	Chairman And Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-04-01	382	$5.99	5,759,656	No	4	P	Direct
Common Stock	Acquisiton	2019-04-02	580	$6.12	5,760,236	No	4	P	Direct
Common Stock	Acquisiton	2019-04-03	80	$6.00	5,760,316	No	4	P	Direct
Common Stock	Acquisiton	2019-04-04	241	$6.19	5,760,557	No	4	P	Direct
Common Stock	Acquisiton	2019-04-05	183	$6.32	5,760,740	No	4	P	Direct
Common Stock	Acquisiton	2019-04-09	60	$6.41	5,760,800	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.